Artificial Intelligence in Lending

Showing 4985 articles
Business

Gilead Sciences Bets on Precision Oncology to Power Next Growth Phase

Gilead Sciences, the biopharma giant known for its HIV treatments, is strategically pivoting to become a major player in cancer therapy. Through targeted licensing and a focus on precision oncology, the company aims to build a multi-billion dollar revenue stream by the end of the decade, reducing its reliance on mature franchises.

Business

Rivian's $7 Billion Bet: Can the R2 SUV Spark an EV Comeback?

With a fortified war chest and production scaling up, Rivian is poised for its most critical test yet: winning over the mass market with its upcoming R2. While the financial runway is clear, the road to profitability hinges on consumer appetite for the new, more affordable model.